fda.gov ยท May 1, 2026 02:41 PM UTC

Drug Trials Snapshot: ROMVIMZA

Drug Trials Snapshot: ROMVIMZA

Summary

The FDA approved ROMVIMZA based on safety and efficacy evidence from one clinical trial (NCT05059262) of 123 patients with TGCT. Learn more about the trial.

Original reporting

Open original source

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Related coverage